. "Retraction: Exploring novel fluorine-rich fuberidazole derivatives as hypoxic cancer inhibitors: Design, synthesis, pharmacokinetics, molecular docking, and DFT evaluations." PLoS ONE, 2026. doi:10.1371/journal.pone.0348537